Immunitybio Inc (IBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 265,453 | 177,963 | 43,506 | 88,481 | 104,641 |
| Marketable Securities | 1,009 | 11,833 | 2,448 | 2,787 | 2,543 |
| Other current assets | 2,019 | 2,325 | 2,025 | 1,464 | 1,890 |
| TOTAL | $294,084 | $215,082 | $66,825 | $113,486 | $140,577 |
| Non-Current Assets | |||||
| PPE Net | 146,082 | 152,000 | 151,487 | 154,165 | 143,659 |
| Investments And Advances | 891 | 817 | 841 | 820 | 840 |
| Intangibles | 17,093 | 18,467 | 18,992 | 19,502 | 20,003 |
| Other Non-Current Assets | 46,302 | 46,053 | 53,082 | 55,427 | 57,277 |
| TOTAL | $210,368 | $217,337 | $224,402 | $229,914 | $221,779 |
| Total Assets | $504,452 | $432,419 | $291,227 | $343,400 | $362,356 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 481,894 | 471,478 | 431,901 |
| Accounts payable and accrued liabilities | 10,331 | 21,090 | 26,647 | 36,505 | 24,485 |
| Accrued Expenses | 42,708 | 64,871 | 62,335 | 54,118 | 41,825 |
| TOTAL | $58,283 | $90,324 | $613,478 | $564,945 | $500,861 |
| Non-Current Liabilities | |||||
| Long Term Debt | 104,586 | 480,020 | 0 | 0 | N/A |
| Other Non-Current Liabilities | 927,542 | 272,780 | 323,266 | 310,411 | 311,426 |
| TOTAL | $1,032,106 | $752,740 | $322,932 | $310,171 | $311,315 |
| Total Liabilities | $1,090,389 | $843,064 | $936,410 | $875,116 | $812,176 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 673,952 | 667,705 | 456,247 | 435,985 | 435,836 |
| Common Shares | 67 | 67 | 44 | 43 | 42 |
| Retained earnings | -2,961,684 | -2,728,292 | -2,632,710 | -2,494,831 | -2,378,488 |
| Other shareholders' equity | 1,060 | 1,864 | -3,107 | -2,766 | -2,310 |
| TOTAL | $-585,937 | $-410,645 | $-645,183 | $-531,716 | $-449,820 |
| Total Liabilities And Equity | $504,452 | $432,419 | $291,227 | $343,400 | $362,356 |